Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 7Breast Neoplasms 5Thyroid Neoplasms 2Stomach Neoplasms 2Recurrence 2Prostatic Neoplasms 2Pilonidal Sinus 2Neuroma 2Neuralgia 2Neoplasm Metastasis 2Head and Neck Neoplasms 2Chronic Pain 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Recurrent Laryngeal Nerve Injuries 1Prostate Biopsy 1Peripheral Nervous System Diseases 1Pain, Postoperative 1Pain, Intractable 1Ovarian Cysts 1Oropharyngeal Neoplasms 1Nevus, Pigmented 1Nerve Block 1Neoplasms 1Melanoma 1Lung Neoplasms 1Localised Prostate Cancer 1Liver Neoplasms 1Invasive Bladder Cancer 1Intracranial Aneurysm 1

Interventions

Ropivacaine 1Lidocaine 1Infusion Pumps, Implantable 1Calcium Dobesilate 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Pain, Intractable × Lidocaine × Clear all
NCT04085120 2019-09-11

Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain

All India Institute of Medical Sciences

Phase NA Unknown
60 enrolled
Head & Neck

Cancer Pain, Oropharyngeal Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡